arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Pluri Inc.

PLUR
$1.56 0.00 (0.00%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
17 Visible periods
25 Metrics
Absolute Benchmarks
Price Chart
38
Health
Weak
Moderately Bullish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, Pluri Inc. shows strong fundamentals, led by Return on Invested Capital. Watch FCF / Net Income against typical quality thresholds. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $9.9M
Dividend Yield
Revenue Growth 309.8%
Op. Margin
ROIC 324.0%
FCF / Share $-3.13
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 4, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.34M
↑ +309.8%
Net Income Profit after all expenses
$-22.58M
↓ -8.1%
FCF / Share Free cash flow per share
$-3.13
↑ +10.6%

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • Return on Invested CapitalReturn on Invested Capital of 324.0% is excellent on an absolute basis (target > 10%)
warning

Bearish Risks

  • FCF / Net IncomeFCF / Net Income of 0.88x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality
38

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 65 quarters